A model for mechanistic investigation of tau protein spread

Kondalarao Bankapalli,Ruth E. Thomas,Evelyn S. Vincow,Gillian Milstein,Laura V. Fisher,Leo J. Pallanck

DOI: https://doi.org/10.1101/2024.04.21.590466

2024-04-25

Abstract:Brain protein aggregates are a hallmark of neurodegenerative disease. Previous work indicates that specific protein components of these aggregates are toxic, including tau in Alzheimer’s disease and related tauopathies. Increasing evidence also indicates that these toxic proteins traffic between cells in a prion-like fashion, thereby spreading pathology from one brain region to another. However, the mechanisms involved in trafficking are poorly understood. We therefore developed a transgenic model to facilitate rapid evaluation of candidate tau trafficking modifiers. Our model uses the bipartite Q system to drive co-expression of tau and GFP in the fly eye. We find age-dependent tau spread into the brain, represented by detection of tau, but not GFP in the brain. We also found that tau trafficking was attenuated upon inhibition of the endocytic factor or the kinase ( ). Further work revealed that dynamin promotes tau uptake in recipient tissues, whereas GSK-3β appears to promote tau spread via direct phosphorylation of tau. Our robust and flexible system will promote the identification of tau trafficking components involved in the pathogenesis of neurodegenerative diseases.

Neuroscience

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to understand the molecular mechanism of how tau protein spreads in the brain in neurodegenerative diseases. Specifically, the authors developed a transgenic Drosophila model for rapidly evaluating candidate modifiers that may affect the inter - cellular transmission of tau protein. Through this model, researchers were able to observe the age - dependent spread of tau protein from the expression site (the eyes of Drosophila) to other regions of the brain, and this spread was not accompanied by the spread of GFP, indicating that the spread of tau protein was not due to the loss of cell integrity.

The key findings of the paper include:

1. **Spread of tau protein**: Tau protein can spread from the eyes to the brain in Drosophila, while GFP does not spread, demonstrating that tau protein has the ability to spread independently of its expression vector.
2. **Factors affecting the spread of tau protein**:
- Inhibiting the endocytosis factor dynamin or the kinase glycogen synthase kinase - 3β (GSK - 3β) can reduce the spread of tau protein.
- Dynamin promotes the uptake of tau protein in receptor tissues, while GSK - 3β promotes its spread by directly phosphorylating tau protein.
3. **Differences in the spread of tau protein and α - synuclein**: Most genetic perturbations that affect the spread of tau protein have no significant impact on the spread of α - synuclein, suggesting that the spread mechanisms of these two proteins may be different.

These findings not only help to understand the spread mechanism of tau protein in neurodegenerative diseases, but also provide a powerful tool for screening and validating new therapeutic targets.